Form D · Biotechnology

JelliSee Ophthalmics Inc.

Mclean, VA · CIK 0002006388

Offering snapshot reported Apr 30, 2024 · SEC filing

Reported sold
$3.73M
Offering amount: $10M
Investors reported
34
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 21, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.86M$3.73MJan 5, 2024: $1,675,000.00Jan 5, 2024Apr 30, 2024: $3,725,000.00Apr 30, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,675,000 → $3,725,000
  • Reported investors15 → 34

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 30, 2024Amendment$3,725,000$2,050,000vs Jan 5, 202434SEC filing
Jan 5, 2024Initial$1,675,000No comparison15SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-501749

Source: Form D, filed Apr 30, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jerry Arthur Director
Dimitri Azar Director
Forrest J Ellis Director, Executive
Adrienne Graves Director
Amy R. Jeffery Director, Executive
Michael J. Malesardi Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
8414 Holly Leaf Dr.
Mclean, VA, 22102